Pros and Cons of Telemedicine in Diagnosis and Management

Telemedicine "healing at a distance" Telemedicine has many advantages especially in time of pandemics for both doctors and patients, low cost and easily accessibility. Pandemics especially COVID 19 has radically change the medical team thoughts about the telemedicine. It can decrease the exposure of the medical team to infection and expected by some of the medical team to be very beneficial if done in good and legal manner. Although, telemedicine has many advantages, also has many disadvantages and medicolegal problems, breakdown in the relationship between medical teams and patients, mis diagnosis or wrong treatment. There are many legal and ethical aspects of telemedicine.

Study Overview

• Status: Enrolling by invitation
• Conditions: the Study Focus on the Uses of Telephone and Other New Technology in Medicine, Diagnosis and Treatment

Detailed Description

Telemedicine "healing at a distance" Telemedicine has many advantages especially in time of pandemics for both doctors and patients, low cost and easily accessibility. Pandemics especially COVID 19 has radically change the medical team thoughts about the telemedicine. It can decrease the exposure of the medical team to infection and expected by some of the medical team to be very beneficial if done in good and legal manner. Although, telemedicine has many advantages, also has many disadvantages and medicolegal problems, breakdown in the relationship between medical teams and patients, mis diagnosis or wrong treatment. There are many legal and ethical aspects of telemedicine. These include the medical responsibilities, the confidentiality and privacy of the patients can not be maintained, the jurisdictional problems. Shortage of medical practitioners and specialists, shortage of internet facilities, low education levels in some patients all are problems facing the telemedicine in developing countries. The evolution of telemedicine poses a series of legal problems ranging from the profiles on the subject of authorization and accreditation to those concerning the protection of patient confidentiality, the definition and solution of which, in the absence of specific regulatory provisions, is mainly left to the assessment of compatibility of the practices adopted so far, with the general regulatory framework.

This research will be done to clarify the role of telemedicine, and if it has a share hand or the upper hand if compared with traditional medicine.

• Study Type: Observational
• Enrollment (Anticipated): 1000

Contacts and Locations

Study Locations

• Egypt
  • Assiut, Egypt, 71515
    • heba Yassa

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 80 years (Adult, Older Adult)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

• Sampling Method: Probability Sample

Study Population

all population can be included in the study

Description

Inclusion Criteria:

• doctors of all specialty
• Patients
• police man and who work in law

Exclusion Criteria:

• No exclusion criteria

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
- To provide an overview about the pros and cons of the telemedicine in Egypt especially in the period of the COVID 19 pandemic.	describe the pros and cons of the telemedicine	6 months
- To assess the impact of telehealth on clinical outcomes from the view of the doctors, patients.	list the impact of telehealth and telemedicine on doctors and patients	6 months

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
- To evaluate the opinion of the law and the malpractice problems that can face doctors due to the use of telemedicine.	List the law opinion about the telemedicine	one year

Collaborators and Investigators

• Sponsor: Heba A Yassa

Publications and helpful links

General Publications

• Ferorelli D, Nardelli L, Spagnolo L, Corradi S, Silvestre M, Misceo F, Marrone M, Zotti F, Mandarelli G, Solarino B, Dell'Erba A. Medical Legal Aspects of Telemedicine in Italy: Application Fields, Professional Liability and Focus on Care Services During the COVID-19 Health Emergency. J Prim Care Community Health. 2020 Jan-Dec;11:2150132720985055. doi: 10.1177/2150132720985055.
• Durupt M, Bouchy O, Christophe S, Kivits J, Boivin JM. [Telemedicine in rural areas: general practitioners' representations and experiences]. Sante Publique. 2016 Oct 19;28(4):487-497. French.
• Ateriya N, Saraf A, Meshram VP, Setia P. Telemedicine and virtual consultation: The Indian perspective. Natl Med J India. 2018 Jul-Aug;31(4):215-218. doi: 10.4103/0970-258X.258220.
• Vidal-Alaball J, Acosta-Roja R, Pastor Hernandez N, Sanchez Luque U, Morrison D, Narejos Perez S, Perez-Llano J, Salvador Verges A, Lopez Segui F. Telemedicine in the face of the COVID-19 pandemic. Aten Primaria. 2020 Jun-Jul;52(6):418-422. doi: 10.1016/j.aprim.2020.04.003. Epub 2020 Apr 17.

Helpful Links

• http://pubmed.ncbi.nlm.nih.gov/32643663/

Study record dates

Study Major Dates

• Study Start (Actual): March 9, 2021
• Primary Completion (Anticipated): August 10, 2021
• Study Completion (Anticipated): February 10, 2022

Study Registration Dates

• First Submitted: February 9, 2021
• First Submitted That Met QC Criteria: February 9, 2021
• First Posted (Actual): February 12, 2021

Study Record Updates

• Last Update Posted (Actual): July 20, 2021
• Last Update Submitted That Met QC Criteria: July 19, 2021
• Last Verified: July 1, 2021

More Information

Terms related to this study

• Keywords: Telemedicine - malpractice - telehealth
• Additional Relevant MeSH Terms: Pathologic Processes; Disease
• Other Study ID Numbers: AssiutU1234

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No